NCT03643991

Brief Summary

The purpose of this research study is to determine whether the use of weighted blankets help reduce behavioral and psychological symptoms, including agitation in people with dementia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 11, 2018

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 20, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 23, 2018

Completed
7.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 28, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
Last Updated

December 29, 2025

Status Verified

December 1, 2025

Enrollment Period

7.6 years

First QC Date

August 20, 2018

Last Update Submit

December 20, 2025

Conditions

Keywords

AgitationDementiaInpatient

Outcome Measures

Primary Outcomes (1)

  • Cohen-Mansfield Agitation Inventory Short Version (CMAI) Change

    Assess the agitation/aggression outcome using numeric scales ranging from 1-5. The sum of the scores is defined as the agitation/aggression outcome and ranges from 14-70, with the lower score being the better outcome.

    At baseline, days 1-3, and then within 72 hours of last use of the weighted blanket

Secondary Outcomes (2)

  • The revised Edmonton Symptom Assessment System Revised (ESAS-r) Change

    At baseline and within 72 hours of the last use of the weighted blanket.

  • Clinical Global Impressions (CGI)

    At baseline, days 1-3, and then within 72 hours of last use of the weighted blanket

Study Arms (2)

Weighted Blanket Cohort

EXPERIMENTAL

Subjects will receive weighted blanket for three nights with monitoring by nurse. Weight of blanket is determined by weight of the patient (10% of patients body weight).

Other: Weighted Blanket

Control Cohort

NO INTERVENTION

Subjects will receive treatment as usual while inpatient, no blanket.

Interventions

Weighted blanket will be given to patients based on the patient weight (10% of patients body weight) for three nights while on inpatient unit.

Weighted Blanket Cohort

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients admitted on the inpatient geriatric psychiatry unit, complex interventions unit, internal medicine service and/or admitted hospice GIP
  • Documented diagnosis of dementia or suspected major neurocognitive disorder.
  • Presence of agitation/aggression symptoms as defined by a minimum aggression score on the Cohen-Mansfield Agitation Inventory Short Version (CMAI): Patients must score 3, 4, or 5 on at least one question related to aggression (items 1-4).
  • Have a LAR able to sign the consent on behalf of the patient.

You may not qualify if:

  • Severe pain likely to be exacerbated by use of weighted blanket
  • Inability to remove blanket;
  • Skin burns or open wounds;
  • Admitted on 72 hour hold.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

Related Publications (1)

  • Schenzel HA, Palmer AK, Shah NB, Lawson DK, Fischer KM, Lapid MI, DeFoster RE. Weighted Blankets for Agitation in Hospitalized Patients with Dementia: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2025 Feb 26;14:e57264. doi: 10.2196/57264.

Related Links

MeSH Terms

Conditions

DementiaPsychomotor Agitation

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental DisordersDyskinesiasNeurologic ManifestationsPsychomotor DisordersNeurobehavioral ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsAberrant Motor Behavior in DementiaBehavioral SymptomsBehavior

Study Officials

  • Maria Lapid, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Enrolled patients will be computer randomized in 1:1 ratio to either the intervention group or the control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

August 20, 2018

First Posted

August 23, 2018

Study Start

April 11, 2018

Primary Completion

October 28, 2025

Study Completion

November 30, 2025

Last Updated

December 29, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations